XML 48 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Share-based Compensation [Abstract]  
Schedule of Information with respect to stock options
 
No. of Shares
 (in thousands)
 
Weighted
Average
Exercise Price
 
Aggregate
 Intrinsic Value (in
thousands)
Outstanding at December 31, 2016
949

 
$
5.22

 
$
264

Options granted
149

 
8.82

 
 
Options exercised
(271
)
 
9.06

 
 
Forfeited and canceled
(31
)
 
5.64

 
 
Expired
(35
)
 
5.17

 
 
Outstanding at December 31, 2017
761

 
$
5.80

 
$
2,748

Vested and expected to vest at December 31, 2017
272

 
$
7.30

 
$
558

Total shares exercisable as of December 31, 2017
41

 
$
5.46

 
$
159

Shares remaining available for grant
687

 
 

 
 

Schedule of assumptions for fair value of options at the date of the grant
The fair value of options at the date of the grant was estimated using the Black-Scholes model with the following assumptions for the respective period ending December 31:
 
2017
2016
Expected option life
3.7 years

5.7 years

Weighted average risk-free interest rate
2.2
%
1.3
%
Weighted average expected volatility
36
%
33
%
Expected dividend yield
0
%
0
%
Schedule of share-based compensation by exercise price range
Stock options outstanding at 2017 are summarized as follows:
Range of
 Exercise Prices
 
Number
Outstanding
(in thousands)
 
Weighted
Average
 Remaining Life
 
Weighted
Average
Exercise
Price
 
 
 
 
 
 
 
$7.15 - $11.01
 
761

 
7.41 years
 
$
5.80

Schedule of activity with respect to non-vested stock options
Current year activity with respect to the Company’s non-vested restricted stock awards is as follows:
Non-vested restricted stock awards (in thousands)
Shares
 
Weighted
Average grant-
date fair value
Balance at January 1, 2017
163

 
$
5.22

Granted
92

 
8.61

Vested
(75
)
 
8.42

Forfeited and canceled
(22
)
 
8.34

Balance at December 31, 2017
158

 
$
6.49